can semaglutide raise liver enzymes GLP-1 and Your Liver: What to Monitor While on or Tirzepatide Semaglutide and Fatty Liver Disease:

Meanwhile, a renewed focus on sugary foods and beverages is gaining steam with the advent of these drugs

If you experience sweating while taking tirzepatide, several strategies can help manage this symptom and improve overall treatment tolerance: For hypoglycemia-related sweating: Monitor blood glucose regularly, especially if taking insulin or sulfonylureas Carry fast-acting carbohydrates (glucose tablets, juice) at all times Follow the "15-15 rule" per American Diabetes Association guidance: consume 15 grams of carbohydrate, wait 15 minutes, and recheck glucose Discuss with your doctor whether adjustment of other diabetes medications is needed If you're at risk for severe hypoglycemia, ask your doctor about glucagon rescue medication For general sweating management: Maintain adequate hydration by drinking water throughout the day, particularly if experiencing gastrointestinal side effects Wear breathable, moisture-wicking fabrics that allow heat dissipation Keep the sleeping environment cool and use lightweight bedding if experiencing night sweats Avoid known triggers such as spicy foods, caffeine, or alcohol, which can exacerbate sweating Practice stress-reduction techniques including deep breathing, meditation, or gentle exercise For gastrointestinal side effects that may contribute to sweating: Eat smaller, more frequent meals rather than large portions Choose bland, easily digestible foods during the initial treatment period Avoid high-fat, greasy, or heavily spiced foods that may worsen nausea Take tirzepatide consistently on the same day each week, with or without food as preferred General treatment optimization: Work closely with your healthcare provider to ensure appropriate dose escalation according to the FDA-approved schedule for your specific medication (Mounjaro or Zepbound)

In a double-blind, placebo-controlled crossover study involving men with erectile dysfunction (ED) of non-organic origin, MT2 induced clinically apparent erections in 8 out of 10 participants, with a mean duration of tip rigidity greater than 80% lasting 38 minutes, compared to only 3 minutes with a placebo

Do not start GLP-1 medication without a licensed provider

Press firmly and wipe for at least 10-15 seconds per vial

Dulaglutide, semaglutide, tirzepatide: potential for altered medicinal product exposure (Tmax, Cmax) when administered with oral medicinal products with rapid gastrointestinal absorption or prolonged release, due to delayed gastric emptying